Message Validation

Validate brand messaging inside the launch window

Concept boards, claim language, ad creative, animatics, finished video — test all stimuli against verified HCP audiences with built-in pre-approval workflow for FDA-relevant content. Multiple concept variants within a single subscription cycle. Monthly subscription — fielding starts the same week the brief is locked.

Stimuli pre-approval workflow built in
Multiple concept variants within one subscription cycle
BAA + FDA-compliant audit trail
Verified clinician on a Carevoices research interview
Live
Intelligence Report Live
0% Message Recall
Mechanism clarity
88%
Differentiation
72%
Action intent
64%
AI Insight

HCPs retain mechanism-of-action framing significantly better than efficacy-stat-led claims when asked to recall messaging unaided.

Carevoices
Benchmark
81%
Live

Trusted by teams at

Nivella Health
TL;DR

Pharma message validation is structurally constrained by FDA compliance: every stimulus (concept board, claim language, ad creative, animatic, finished video) requires medical regulatory pre-approval before exposure to HCP respondents. Generic AI research tools don't have stimuli pre-approval workflow; legacy vendors bolt compliance documentation on as a separate line item. Message validation within Carevoices' monthly subscription includes versioned stimuli upload, lock workflow, audit trail per panelist per stimulus, and AI-moderated depth on resonance, optimization, and decision triggers — fielding starts the same week the brief is locked, with the compliance package bundled in. 50 interviews/month included means brand teams can iterate on stimuli without per-study procurement cycles. Used for pre-launch validation, claim testing, ad creative resonance, and iterative concept refinement across pharma brand engagements.

The Problem

Why Message Validation Is Hard at Pace

Three structural constraints generic research tools don't address.

01

FDA-relevant stimuli require medical regulatory pre-approval

Every concept board, claim, animatic, or finished ad must pass internal medical regulatory review before HCP exposure. Generic AI research tools don't have versioned stimuli + audit trail workflow. Legacy vendors bolt the compliance package on as a separate line item per study, and Sunshine Act handling for HCP honoraria adds documentation overhead.

02

HCP recruitment takes 6-10 weeks at incumbent vendors

Brand teams need iteration: test variant A, refine, test variant B, refine, finalize. 6-10 week recruitment cycles compress this to one-shot validation. Same-week fielding once the brief is locked is the only structure that lets brand teams iterate inside the launch window.

03

Per-study procurement breaks iterative stimuli refinement

Brand teams want to test, refine, and re-test claims and creative inside campaign timelines. Per-study procurement on each variant cycle adds weeks of re-scoping, re-contracting, and re-paneling between rounds. Brand teams need a structure where multiple stimuli rounds run within one subscription cycle.

Use Cases

Real-world applications
for Message Validation

Compliance Built In

BAA on every engagement. HIPAA Safe Harbor de-identification by default. US data residency confirmed in writing. Stimuli pre-approval workflow with versioning and audit trail per panelist per stimulus for FDA-relevant content. Sunshine Act-ready handling for HCP honoraria.

Pharma compliance + medical regulatory teams clear the engagement in 5-10 business days

Faster Insights

Same-week fielding once the brief is locked, so brand teams can iterate stimuli inside the launch window. AI-moderated voice and video interviews with verified HCPs from a 10k+ healthcare panel. Recruitment runs 7-14 days for mainstream specialties; 14-28 days for rare subspecialties.

Stimuli validation rounds delivered in under 2 weeks vs. 6-10 weeks at legacy vendors

Always-On Listening

Monthly subscription with 50 interviews/month included means iteration on stimuli across rounds within one subscription cycle — no per-round procurement. Run round 1 (concept boards), round 2 (refined claims), round 3 (animatic / finished video) all under one engagement.

Iterate on stimuli inside a single subscription cycle without re-procurement
Compare

How Carevoices message validation compares to common alternatives

Dimension Carevoices Sermo / M3 panel rentalsZoomRx / typical RFP-driven CROGeneric AI tools (Outset / Listen Labs)
Engagement model Monthly subscription with 50 interviews included; same-week fielding Annual panel access subscription + per-survey feesRFP-driven custom engagement, 30-90 day procurementCustom RFP-driven engagement design
BAA on every engagement Yes — template available pre-signature Yes — standard for pharma engagementsYes — standard for pharma engagementsNo published BAA template; 60-120+ day legal retrofit
AI-moderated voice/video qualitative Native — primary delivery mechanism for resonance depth Survey + community methodologyHybrid AI + human moderationYes — but no healthcare compliance package
Stimuli pre-approval workflow for FDA-relevant content Native — versioning + audit trail per panelist per stimulus Survey-based; not designed for FDA-relevant stimuli testingAvailable, layered onto custom engagementNot built for FDA-relevant content
Iteration speed inside a launch window Multiple stimuli rounds within one subscription cycle Per-survey fees on every roundNew RFP cycle per roundCustom-scoped per round; no compliance reuse
How It Works

From question to intelligence

1
Day 1

Messages and audience lock

Submit message variants (with regulatory pre-clearance status), define target segments, and confirm stimuli pre-approval scope.

2
Days 2–14

AI-moderated message-validation interviews

Voice or video interviews — laddered probes on each message: clarity, credibility, persuasiveness, switching influence.

3
Days 15–21

Compliant deliverable

De-identified transcripts plus message-by-message evidence delivered to your analysis stack with audit log.

"We were CROs competing on speed alone, but patient research was the bottleneck — we would quote 8-week timelines while sponsors went to bigger firms in the US and Europe. Carevoices changed the math. We ran 1,203 patient interviews in 48 hours for one sponsor, with HIPAA-grade de-identified transcripts delivered straight into our analysis stack, and the AI moderator went deeper than our human moderators on the first round. Sponsors come to us specifically now because we can do depth research at scale — 34% recruitment uplift, 52% retention. We can now compete globally because of Carevoices."

Stephane Nyombaire, CEO, Nivella Health

Methodology & Trust

How Carevoices Runs Message Validation

Message validation needs stimuli pre-approval, audience specificity, and laddering past surface reactions — to surface what actually moves prescribing intent.

How we recruit

  • License + NPI verified clinicians, segmented by category experience and prescribing authority
  • Stratified recruit for cross-segment message-resonance comparisons (academic vs. community, specialist vs. PCP, etc.)
  • Behavioral fingerprinting across interviews — message reactions are real, not AI-generated

How we deliver

  • Stimuli pre-approval workflow handles regulated message variants (claims, supporting data, framing)
  • AI-moderated laddering surfaces what's persuasive vs. memorable vs. credible — the three usually diverge
  • Verbatim evidence plus de-identified transcripts ready for your analysis stack and cross-coding
Get Started

Validate your next message inside the launch window

30-min walkthrough of message validation workflow. Sample stimuli pre-approval audit trail. Scoping for your specific message-testing engagement.

30-min with founder

Sample message validation deliverable + stimuli pre-approval workflow walkthrough

Stimuli approval methodology

BAA + audit trail + identifier stripping documentation for medical regulatory review

Most engagements clear procurement within 30-60 days at top-20 pharma.

FAQ

Common questions

Yes. Stimuli upload, version, lock workflow built in. Only approved stimuli can launch to participants. Audit trail per panelist per stimulus. Designed for FDA-relevant content review by your medical regulatory team.
Carevoices is a monthly subscription with 50 interviews included — fielding starts the same week the brief is locked, with BAA, HIPAA Safe Harbor de-identification, US data residency, and stimuli pre-approval audit trail bundled. Additional interviews above 50/month at standard credit rate. Legacy vendors typically run 6-10 weeks per study and bolt compliance on as a separate line item. AI-native moderation collapses analysis time without sacrificing depth.
Sermo and M3 are panel-access subscriptions — annual fees plus per-survey fees, with you assembling moderation and de-identification. Carevoices is a delivered-study subscription bundling recruitment, AI voice/video, transcription, HIPAA Safe Harbor, BAA, and stimuli pre-approval. Sermo and M3 are stronger for international panel breadth; Carevoices is built for message validation where same-week fielding and built-in stimuli pre-approval matter more.
Generic AI research tools were built for consumer brands and haven't retrofit healthcare compliance. Most don't publish a BAA template, don't run license + NPI verification, don't de-identify to HIPAA Safe Harbor by default, and lack stimuli pre-approval for FDA content. Pharma compliance disqualifies them at the BAA or stimuli-approval gate. Carevoices is healthcare-purpose-built: versioned stimuli upload, audit trail, BAA, HIPAA Safe Harbor, Sunshine Act native.